Legacy Wealth Management (Idaho)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$533K Buy
445
+333
+297% +$340K 0.22% 105
2026
Q1
$103K Buy
112
+13
+13% +$13.2K 0.05% 175
2025
Q4
$106K Buy
99
+92
+1,314% +$88K 0.05% 140
2025
Q3
$5.34K Hold
7
﹤0.01% 425
2025
Q2
$5.46K Hold
7
﹤0.01% 390
2025
Q1
$5.78K Hold
7
﹤0.01% 405
2024
Q4
$6.15K Buy
+7
New +$5.8K ﹤0.01% 357

Other funds holding LLY

Legacy Wealth Management (Idaho)'s LLY Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) increased its Eli Lilly (LLY) stake by 297% in Q2 2026, buying an estimated $340K and bringing the position to 445 shares worth $533K. The position accounts for 0.22% of the portfolio, ranked #105.

Legacy Wealth Management (Idaho) first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Legacy Wealth Management (Idaho) held 445 shares of Eli Lilly worth $533K as of Q2 2026.
  • Legacy Wealth Management (Idaho) bought 333 Eli Lilly shares in Q2 2026, an estimated $340K.
  • Eli Lilly made up 0.22% of Legacy Wealth Management (Idaho)'s portfolio in Q2 2026, its #105 holding.
  • Legacy Wealth Management (Idaho) first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.